Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
507
|
203
|
0.400 |
None |
0.968 |
1 |
|
2009 |
2020 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
266
|
173
|
0.400 |
None |
0.979 |
1 |
|
2015 |
2020 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
40
|
19
|
0.400 |
None |
0.966 |
1 |
|
2011 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
265
|
|
0.400 |
None |
1.000 |
1 |
|
2004 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
128
|
202
|
0.400 |
None |
0.979 |
0 |
|
2003 |
2020 |
Adult Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
5
|
4
|
0.400 |
None |
0.952 |
0 |
|
2016 |
2020 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
55
|
19
|
0.400 |
None |
0.981 |
0 |
|
2011 |
2020 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
81
|
0.400 |
None |
1.000 |
0 |
|
2008 |
2020 |
Hypersensitivity
|
group |
Immune System Diseases
|
Pathologic Function
|
64
|
2
|
0.300 |
None |
1.000 |
2 |
|
2010 |
2013 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
63
|
1019
|
0.300 |
None |
1.000 |
2 |
|
2010 |
2013 |
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
1
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
1
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug Dependence
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Malignant neoplasm of thymus
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Radiation-Induced Cancer
|
disease |
Neoplasms; Wounds and Injuries
|
Neoplastic Process
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Substance abuse problem
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
18
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Disease Exacerbation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
165
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Substance Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
1
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neoplasms, Radiation-Induced
|
phenotype |
Neoplasms; Wounds and Injuries
|
Neoplastic Process
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |